{"status": "ok", "totalResults": 3, "articles": [{"source": {"id": null, "name": "YouTube"}, "author": null, "title": "UK approves gene therapy to cure two blood disorders - BBC News - BBC News", "description": "In a world first, medical regulators in the UK have approved a gene therapy that aims to cure sickle cell disease and beta thalassemia. The treatment is the ...", "url": "https://www.youtube.com/watch?v=BOjceonSiTY", "urlToImage": "https://i.ytimg.com/vi/BOjceonSiTY/maxresdefault.jpg", "publishedAt": "2023-11-18T08:50:21Z", "content": null}, {"source": {"id": null, "name": "FX Empire"}, "author": null, "title": "Natural Gas, WTI Oil, Brent Oil Forecasts \u2013 Oil Soars As OPEC+ May Deepen Production Cuts - FX Empire", "description": "According to a recent report, OPEC+ will discuss additional supply cuts when the group meets at the end of November.", "url": "https://www.fxempire.com/forecasts/article/natural-gas-wti-oil-brent-oil-forecasts-oil-soars-as-opec-may-deepen-production-cuts-1389577", "urlToImage": "https://responsive.fxempire.com/width/600/webp-lossy-70.q50/_fxempire_/2023/11/Oil-Pump-3.jpg", "publishedAt": "2023-11-17T17:48:00Z", "content": "Brent Oil 171123 Daily Chart\r\nBrent oil has also gained strong momentum as changes in OPEC+ production plans may lead to serious changes in the supply/demand balance.\r\nTo continue the rebound, Brent \u2026 [+172 chars]"}, {"source": {"id": null, "name": "FiercePharma"}, "author": "FiercePharma", "title": "AstraZeneca's first-in-class FDA approval for Truqap marred by surprise restriction - FiercePharma", "description": null, "url": "https://www.fiercepharma.com/pharma/astrazenecas-first-class-truqap-approval-breast-cancer-marred-surprise-restriction", "urlToImage": null, "publishedAt": "2023-11-17T16:02:00Z", "content": null}]}